Jan Astermark

151 – 160 of 191

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af7e247a-381e-4a1c-a1d8-7625b1488a9e?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
15
16
17
18
…
20
next »

2006
Mark Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.
Astermark, Jan ^LU (2006) In Haemophilia 12 Suppl 3. p.52-60
- Contribution to journal › Article
Mark Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
Astermark, Jan ^LU ; Morado, M ; Rocino, A ; van den Berg, H M ; von Depka, M ; Gringeri, A ; Mantovani, L ; Garrido, R P ; Schiavoni, M and Villar, A , et al. (2006) In Haemophilia 12(4). p.363-371
- Contribution to journal › Article
Mark Polymorphisms in the IL-10 but not in the IL-1{beta} and IL-4 genes are associated with inhibitor development in patients with hemophilia A.
Astermark, Jan ^LU ; Oldenburg, Johannes ; Pavlova, Anna ; Berntorp, Erik ^LU and Lefvert, Ann-Kari (2006) In Blood 107(8). p.3167-3172
- Contribution to journal › Article
2005
Mark Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Donfield, S M ; Nelson, G W ; Oldenburg, J ; Shapiro, A D ; Dimichele, D M ; Ewenstein, B M ; Gomperts, E D and Winkler, C A (2005) In Haemophilia 11(4). p.427-429
- Contribution to journal › Letter
Mark The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A.
Astermark, Jan ^LU ; Oldenburg, Johannes ; Escobar, Miguel ; White, Gilbert C and Berntorp, Erik ^LU (2005) In Haematologica 90(7). p.924-930
- Contribution to journal › Article
Mark Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survival.
Nilsson, Gunnar ^LU ; Astermark, Jan ^LU ; Lethagen, Stefan ^LU ; Vernersson, Einar ^LU and Berntorp, Erik ^LU (2005) In Thrombosis Research 116(1). p.15-24
- Contribution to journal › Article
2003
Mark When to start and when to stop primary prophylaxis in patients with severe haemophilia.
Astermark, Jan ^LU (2003) In Haemophilia 9(Suppl 1). p.32-36
- Contribution to journal › Article
Mark Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Björkman, S ; Blanchette, V. S. ; Fischer, K. ; Giangrande, P. L. F. ; Gringeri, A. ; Ljung, Rolf ^LU ; Manco-Johnson, M. J. and Morfini, M. , et al. (2003) In Haemophilia 9(Suppl 1). p.41278-41278
- Contribution to journal › Letter
Mark Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro.
Astermark, Jan ^LU ; Voorberg, J. ; Lenk, H. ; DiMichele, D. ; Shapiro, A. ; Tjönnfjord, G. and Berntorp, Erik ^LU (2003) In Haemophilia 9(5). p.567-572
- Contribution to journal › Article
Mark Treatment of the bleeding inhibitor patient
Astermark, Jan ^LU (2003) In Seminars in Thrombosis and Hemostasis 29(1). p.77-85
- Contribution to journal › Article

« previous
1
…
15
16
17
18
…
20
next »